- Home
- DUOL vs ICLR Comparison
DUOL vs ICLR Comparison
Compare DUOL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUOL
- ICLR
- Stock Information
- Founded
- DUOL 2011
- ICLR 1990
- Country
- DUOL United States
- ICLR Ireland
- Employees
- DUOL N/A
- ICLR N/A
- Industry
- DUOL Computer Software: Prepackaged Software
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DUOL Technology
- ICLR Health Care
- Exchange
- DUOL Nasdaq
- ICLR Nasdaq
- Market Cap
- DUOL 13.3B
- ICLR 13.7B
- IPO Year
- DUOL 2021
- ICLR 1998
- Fundamental
- Price
- DUOL $289.67
- ICLR $179.43
- Analyst Decision
- DUOL Buy
- ICLR Buy
- Analyst Count
- DUOL 18
- ICLR 15
- Target Price
- DUOL $413.65
- ICLR $209.93
- AVG Volume (30 Days)
- DUOL 2.0M
- ICLR 1.1M
- Earning Date
- DUOL 11-05-2025
- ICLR 10-22-2025
- Dividend Yield
- DUOL N/A
- ICLR N/A
- EPS Growth
- DUOL 73.11
- ICLR 13.11
- EPS
- DUOL 2.46
- ICLR 9.73
- Revenue
- DUOL $885,152,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- DUOL $38.77
- ICLR N/A
- Revenue Next Year
- DUOL $26.01
- ICLR $1.42
- P/E Ratio
- DUOL $118.08
- ICLR $18.00
- Revenue Growth
- DUOL 39.51
- ICLR N/A
- 52 Week Low
- DUOL $241.49
- ICLR $125.10
- 52 Week High
- DUOL $544.93
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- DUOL 43.19
- ICLR 57.29
- Support Level
- DUOL $264.85
- ICLR $164.00
- Resistance Level
- DUOL $319.68
- ICLR $177.00
- Average True Range (ATR)
- DUOL 17.97
- ICLR 6.83
- MACD
- DUOL 2.05
- ICLR -0.26
- Stochastic Oscillator
- DUOL 52.09
- ICLR 85.04
About DUOL Duolingo Inc.
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.